Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

33.23
Delayed Data
As of Dec 02
 +1.33 / +4.15%
Today’s Change
17.92
Today|||52-Week Range
34.42
+10.05%
Year-to-Date
No recent news for AMAG Pharmaceuticals Inc.

Today’s Trading

Previous close31.90
Today’s open31.90
Day’s range31.40 - 34.00
Volume862,221
Average volume (3 months)828,891
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-82.73%
Earnings growth (this year)+543.87%
Earnings growth (next 5 years)+0.02%
Revenue growth (last year)+236.28%
P/E ratio77.3
Price/Sales2.55
Price/Book1.19

Competitors

 Today’s
change
Today’s
% change
MNTAMomenta Pharmaceutic...+0.35+2.54%
CHRSCoherus BioSciences ...+0.35+1.27%
XLRNAcceleron Pharma Inc+1.25+3.57%
CRSPCRISPR Therapeutics ...-0.95-4.75%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 3, 2017
EPS forecast (this quarter)$1.84
Annual revenue (last year)$418.3M
Annual profit (last year)$32.8M
Net profit margin7.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs